Moret C, Briley M
Department of Biochemical Pharmacology, Pierre Fabre Research Centre, Castres, France.
Neuropharmacology. 1988 Jan;27(1):43-9. doi: 10.1016/0028-3908(88)90199-2.
The effect of midalcipran, an equipotent inhibitor of the uptake of 5-hydroxytryptamine (5-HT) and noradrenaline (NA), on the inhibition of release of 5-HT induced by lysergic acid diethylamide (LSD), was investigated by studying the overflow of transmitter from slices of hypothalamus from the rat prelabelled with [3H]5-HT. The (Z)-enantiomer of midalcipran, at 0.1 microM, displaced to the right the concentration-effect curve of inhibition of release of [3H]5-HT elicited by electrical stimulation induced by LSD. In contrast, the (E)-enantiomer, which does not inhibit the uptake of monoamines, was devoid of any antagonizing effect. The inhibitory effect of 0.1 microM LSD was not modified in the presence of maprotiline, bupropion or mianserin at 1 microM. The results of this study show that the interaction between the 5-HT autoreceptor and the inhibitors of the uptake of 5-HT is related exclusively to their potency at inhibiting the uptake of 5-HT. The effect of the monoamine oxidase inhibitor, pargyline (1-10 microM), was also studied on the field-stimulated release of [3H]5-HT. The inhibitory effect of this drug was antagonized by methiothepin at 0.1 and 1 microM, by phentolamine 1 microM and 10 microM and by the inhibitor of the uptake of 5-HT, citalopram at 0.1 and 1 microM. The action of pargyline appeared to be mediated through the activation of the serotonergic autoreceptor and of the presynaptic alpha-adrenoceptor located on serotonergic nerve terminals. The results obtained with pargyline are consistent with the hypothesis of an interaction between the 5-HT autoreceptor and the uptake site for 5-HT.(ABSTRACT TRUNCATED AT 250 WORDS)
通过研究用[3H]5-羟色胺(5-HT)预标记的大鼠下丘脑切片中递质的溢出情况,研究了米氮平(一种对5-羟色胺(5-HT)和去甲肾上腺素(NA)摄取具有同等效力的抑制剂)对麦角酸二乙酰胺(LSD)诱导的5-HT释放抑制作用的影响。米氮平的(Z)-对映体在0.1微摩尔浓度时,使LSD诱导的电刺激引起的[3H]5-HT释放抑制浓度-效应曲线向右移动。相比之下,不抑制单胺摄取的(E)-对映体则没有任何拮抗作用。在存在1微摩尔浓度的马普替林、安非他酮或米安色林时,0.1微摩尔浓度LSD的抑制作用未改变。本研究结果表明,5-HT自身受体与5-HT摄取抑制剂之间的相互作用仅与其抑制5-HT摄取的效力有关。还研究了单胺氧化酶抑制剂帕吉林(1 - 10微摩尔)对电场刺激的[3H]5-HT释放的影响。该药物的抑制作用在0.1和1微摩尔浓度的甲硫噻平、1微摩尔和10微摩尔浓度的酚妥拉明以及0.1和1微摩尔浓度的5-HT摄取抑制剂西酞普兰存在时被拮抗。帕吉林的作用似乎是通过激活位于5-羟色胺能神经末梢的5-羟色胺能自身受体和突触前α-肾上腺素受体介导的。用帕吉林获得的结果与5-HT自身受体和5-HT摄取位点之间相互作用的假设一致。(摘要截短至250字)